October 13, 2026
Earnings announcement
- EPS
- $2.59
- est $2.52 · +2.8%
- Revenue
- $25.40B
- est $25.38B · +0.1%
Guidance, report highlights and next-day price reaction are not supplied by this earnings feed.
NYSE · Healthcare
JNJ
Johnson & Johnson
FMP · Retrieved 11/12/2026, 8:10:10 PM · Refreshes at most once per minute · Quotes may be delayed
Saved data · FMP's request limit has been reached. Try again later.
- Share price
- $284.88
- +1.6%
- Market cap
- $685.78B
- USD
- Exchange
- NYSE
- Healthcare
Earnings watch
January 26, 2027
74 days until report · Time not supplied by FMP
EPS estimate $2.91 · Revenue estimate $26.42B
Latest report
Beat
EPS history · actual vs. estimate
■ Estimate■ Actual
26-01-21$2.46
26-04-14$2.70
26-07-15$2.90
26-10-13$2.59
Bar height shows EPS magnitude; signed actual values appear below each bar.
Past reports
July 15, 2026
Earnings announcement
- EPS
- $2.90
- est $2.85 · +1.8%
- Revenue
- $25.31B
- est $25.06B · +1.0%
April 14, 2026
Earnings announcement
- EPS
- $2.70
- est $2.68 · +0.7%
- Revenue
- $24.06B
- est $23.61B · +1.9%
January 21, 2026
Earnings announcement
- EPS
- $2.46
- est $2.46 · +0.0%
- Revenue
- $24.56B
- est $24.15B · +1.7%
Up to five announcement records from your FMP plan. Figures use FMP’s reported basis; fiscal periods and GAAP/adjusted classifications are not supplied.
About Johnson & Johnson
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Company website ↗